Skip to main content
Erschienen in: Metabolic Brain Disease 2/2014

01.06.2014 | Original Paper

HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda

verfasst von: Ned Sacktor, Noeline Nakasujja, Andrew D. Redd, Jordyn Manucci, Oliver Laeyendecker, Sarah K. Wendel, Stephen F Porcella, Craig Martens, Daniel Bruno, Richard L. Skolasky, Ozioma C. Okonkwo, Kevin Robertson, Seggane Musisi, Elly Katabira, Thomas C. Quinn

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

HIV-associated neurocognitive disorders (HAND) are a common neurological manifestation of HIV infection. A previous study suggested that HIV dementia may be more common among patients with subtype D virus than among those with subtype A virus among HIV+ individuals with advanced immunosuppression. We conducted a study to evaluate the frequency of HIV dementia, and the association of HIV dementia with HIV subtype and compartmentalization among HIV+ individuals with moderate and advanced immunosuppression (CD4 lymphocyte count >150 cells/μL and <250 cells/μL). The study enrolled 117 antiretroviral naïve HIV+ individuals in Kampala, Uganda. HIV+ individuals received neurological, neuropsychological testing, and functional assessments, and gag and gp41 regions were subtyped. Subjects were considered infected with a specific subtype if both regions analyzed were from the same subtype. 41 % of the HIV+ individuals had HIV dementia (mean CD4 lymphocyte count = 233 cells/μL). 67 individuals had subtype A, 25 individuals had subtype D, 24 individuals were classified as A/D recombinants, and one individual had subtype C. There was no difference in the frequency of HIV dementia when stratified by HIV subtype A and D and no association with compartmentalization between the cerebrospinal fluid and peripheral blood. These results suggest that HIV dementia is common in HIV+ individuals in Uganda. There was no association between HIV subtype and dementia among HIV+ individuals with moderate and advanced immunosuppression. Future studies should be performed to confirm these results.
Literatur
Zurück zum Zitat Antinori A, Arendt G, Becker JT, Brew BJ, Byrd D et al (2007) Updated research nosology for HIV-associated neurocognitive disorders (HAND). Neurology 69(18):1789–1799PubMedCrossRef Antinori A, Arendt G, Becker JT, Brew BJ, Byrd D et al (2007) Updated research nosology for HIV-associated neurocognitive disorders (HAND). Neurology 69(18):1789–1799PubMedCrossRef
Zurück zum Zitat Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS et al (2007) HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 195(8):1177–1180PubMedCrossRef Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS et al (2007) HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 195(8):1177–1180PubMedCrossRef
Zurück zum Zitat Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H et al (2010) HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS 24(8):1163–1170PubMedCentralPubMedCrossRef Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H et al (2010) HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS 24(8):1163–1170PubMedCentralPubMedCrossRef
Zurück zum Zitat Carr JK, Salminen MO, Koch C, Gotte D, Artenstein AW et al (1996) Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 70(9):5935–5943PubMedCentralPubMed Carr JK, Salminen MO, Koch C, Gotte D, Artenstein AW et al (1996) Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 70(9):5935–5943PubMedCentralPubMed
Zurück zum Zitat Conroy SA, Laeyendecker O, Redd AD, Collinson-Streng A, Kong X et al (2010) Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. AIDS Res Hum Retrovir 26(10):1087–1091PubMedCentralPubMedCrossRef Conroy SA, Laeyendecker O, Redd AD, Collinson-Streng A, Kong X et al (2010) Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. AIDS Res Hum Retrovir 26(10):1087–1091PubMedCentralPubMedCrossRef
Zurück zum Zitat Felsentein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791CrossRef Felsentein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791CrossRef
Zurück zum Zitat Gabuzda D, Wang J (2000) Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol 6(Suppl 1):S24–S32PubMed Gabuzda D, Wang J (2000) Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol 6(Suppl 1):S24–S32PubMed
Zurück zum Zitat Hall TA (1999) BioEdit: a user-friendly biological sequencealignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:95–98 Hall TA (1999) BioEdit: a user-friendly biological sequencealignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:95–98
Zurück zum Zitat Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K et al (2009) Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS 23(8):907–915PubMedCentralPubMedCrossRef Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K et al (2009) Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS 23(8):907–915PubMedCentralPubMedCrossRef
Zurück zum Zitat Kaleebu P, French N, Mahe C, Yirrell D, Watera C et al (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185(9):1244–1250PubMedCrossRef Kaleebu P, French N, Mahe C, Yirrell D, Watera C et al (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185(9):1244–1250PubMedCrossRef
Zurück zum Zitat Kaleebu P, Nankya IL, Yirrell DL, Shafer LA, Kyosiimire-Lugemwa J et al (2007) Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr 45(1):28–33PubMedCrossRef Kaleebu P, Nankya IL, Yirrell DL, Shafer LA, Kyosiimire-Lugemwa J et al (2007) Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr 45(1):28–33PubMedCrossRef
Zurück zum Zitat Karnofsky DA, Abelman WH, Craver LF, Burchenal J (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656CrossRef Karnofsky DA, Abelman WH, Craver LF, Burchenal J (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656CrossRef
Zurück zum Zitat Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M et al (2008) Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 197(5):707–713PubMedCrossRef Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M et al (2008) Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 197(5):707–713PubMedCrossRef
Zurück zum Zitat Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS et al (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73(1):152–160PubMedCentralPubMed Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS et al (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73(1):152–160PubMedCentralPubMed
Zurück zum Zitat Maj M, Satz P, Janssen R, Zaudig M, Starace F et al (1994) WHO Neuropsychiatric AIDS Study. Cross-sectional Phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry 51:51–61PubMedCrossRef Maj M, Satz P, Janssen R, Zaudig M, Starace F et al (1994) WHO Neuropsychiatric AIDS Study. Cross-sectional Phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry 51:51–61PubMedCrossRef
Zurück zum Zitat Redd AD, Collinson-Streng A, Martens C, Ricklefs S, Mullis CE et al (2011) Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J Clin Microbiol 49(8):2859–2867PubMedCentralPubMedCrossRef Redd AD, Collinson-Streng A, Martens C, Ricklefs S, Mullis CE et al (2011) Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J Clin Microbiol 49(8):2859–2867PubMedCentralPubMedCrossRef
Zurück zum Zitat Redd AD, Mullis CE, Serwadda D, Kong X, Martens C et al (2012) The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J Infect Dis 206(2):267–274PubMedCentralPubMedCrossRef Redd AD, Mullis CE, Serwadda D, Kong X, Martens C et al (2012) The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J Infect Dis 206(2):267–274PubMedCentralPubMedCrossRef
Zurück zum Zitat Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E et al (2007) Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol 7:8PubMedCentralPubMedCrossRef Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E et al (2007) Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol 7:8PubMedCentralPubMedCrossRef
Zurück zum Zitat Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA et al (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19(13):1367–1374PubMed Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA et al (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19(13):1367–1374PubMed
Zurück zum Zitat Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M et al (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67(2):311–314PubMedCrossRef Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M et al (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67(2):311–314PubMedCrossRef
Zurück zum Zitat Sacktor N, Nakasujja N, Skolasky R, Liner J, Robertson K et al (2007) Neurocognitive improvement with antiretroviral therapy among HIV+ individuals in Sub-Saharan Africa. Neurology A:139–40 (Abstr.) Sacktor N, Nakasujja N, Skolasky R, Liner J, Robertson K et al (2007) Neurocognitive improvement with antiretroviral therapy among HIV+ individuals in Sub-Saharan Africa. Neurology A:139–40 (Abstr.)
Zurück zum Zitat Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K et al (2009) HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49(5):780–786PubMedCentralPubMedCrossRef Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K et al (2009) HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49(5):780–786PubMedCentralPubMedCrossRef
Zurück zum Zitat Sacktor N, Nakasujja N, Okonkwo O, Skolasky RL, Robertson K et al (2013) Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda. J Neurovirol 19(1):48–56PubMedCentralPubMedCrossRef Sacktor N, Nakasujja N, Okonkwo O, Skolasky RL, Robertson K et al (2013) Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda. J Neurovirol 19(1):48–56PubMedCentralPubMedCrossRef
Zurück zum Zitat Smith A (1982) Symbol digit modalities test. Western psychological service Smith A (1982) Symbol digit modalities test. Western psychological service
Zurück zum Zitat Vallat AV, DeGirolami U, He JL, Mhashilkar A, Marasco W et al (1998) Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152:167–178PubMedCentralPubMed Vallat AV, DeGirolami U, He JL, Mhashilkar A, Marasco W et al (1998) Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152:167–178PubMedCentralPubMed
Zurück zum Zitat Wambui V, Kiptoo M, Kinyua J, Odera I, Muge E et al (2012) Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic. AIDS Res Ther 9(1):22PubMedCentralPubMedCrossRef Wambui V, Kiptoo M, Kinyua J, Odera I, Muge E et al (2012) Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic. AIDS Res Ther 9(1):22PubMedCentralPubMedCrossRef
Zurück zum Zitat Wong M, Robertson K, Nakasujja N, Skolasky R, Musisi S et al (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68:350–355PubMedCrossRef Wong M, Robertson K, Nakasujja N, Skolasky R, Musisi S et al (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68:350–355PubMedCrossRef
Zurück zum Zitat Yang C, Dash BC, Simon F, van der GG, Pieniazek D et al (2000) Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis 181(5):1791–1795PubMedCrossRef Yang C, Dash BC, Simon F, van der GG, Pieniazek D et al (2000) Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis 181(5):1791–1795PubMedCrossRef
Zurück zum Zitat Yang C, Dash B, Hanna SL, Frances HS, Nzilambi N et al (2001) Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa. Democratic Republic of Congo. AIDS Res Hum Retrovir 17(4):361–365PubMedCrossRef Yang C, Dash B, Hanna SL, Frances HS, Nzilambi N et al (2001) Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa. Democratic Republic of Congo. AIDS Res Hum Retrovir 17(4):361–365PubMedCrossRef
Metadaten
Titel
HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda
verfasst von
Ned Sacktor
Noeline Nakasujja
Andrew D. Redd
Jordyn Manucci
Oliver Laeyendecker
Sarah K. Wendel
Stephen F Porcella
Craig Martens
Daniel Bruno
Richard L. Skolasky
Ozioma C. Okonkwo
Kevin Robertson
Seggane Musisi
Elly Katabira
Thomas C. Quinn
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 2/2014
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-014-9498-3

Weitere Artikel der Ausgabe 2/2014

Metabolic Brain Disease 2/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.